PROCEPT BioRobotics Corporation (PRCT)

PROCEPT BioRobotics Corporation (PRCT) scores 38 out of 100 on boothcheck's 11-model valuation framework. Verdict: Strong Avoid The estimated fair value is $-1.97, representing a 1234% premium to fair value.

Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.

View full PRCT analysis on boothcheck